C148H147F6N21O17S2 — CID 161397962
N-[3-(2-aminoethoxy)phenyl]-4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]pyrimidin-2-amine;tert-butyl 4-[2-[3-[[4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]pyrimidin-2-yl]amino]phenoxy]ethyl]piperazine-1-carboxylate;4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-N-[3-(2-methylsulfonylethyl)phenyl]pyrimidin-2-amine;4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-N-[4-(methylsulfonylmethyl)phenyl]pyrimidin-2-amine;4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-N-[3-(oxan-4-yloxy)phenyl]pyrimidin-2-amine;1-[3-[[4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]pyrimidin-2-yl]amino]phenyl]pentan-1-one (PubChem CID 161397962) has the molecular formula C148H147F6N21O17S2 and a molecular weight of 2670.06 g/mol. Its IUPAC name is N-[3-(2-aminoethoxy)phenyl]-4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]pyrimidin-2-amine;tert-butyl 4-[2-[3-[[4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]pyrimidin-2-yl]amino]phenoxy]ethyl]piperazine-1-carboxylate;4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-N-[3-(2-methylsulfonylethyl)phenyl]pyrimidin-2-amine;4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-N-[4-(methylsulfonylmethyl)phenyl]pyrimidin-2-amine;4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-N-[3-(oxan-4-yloxy)phenyl]pyrimidin-2-amine;1-[3-[[4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]pyrimidin-2-yl]amino]phenyl]pentan-1-one.
| Compound Name | N-[3-(2-aminoethoxy)phenyl]-4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]pyrimidin-2-amine;tert-butyl 4-[2-[3-[[4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]pyrimidin-2-yl]amino]phenoxy]ethyl]piperazine-1-carboxylate;4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-N-[3-(2-methylsulfonylethyl)phenyl]pyrimidin-2-amine;4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-N-[4-(methylsulfonylmethyl)phenyl]pyrimidin-2-amine;4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-N-[3-(oxan-4-yloxy)phenyl]pyrimidin-2-amine;1-[3-[[4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]pyrimidin-2-yl]amino]phenyl]pentan-1-one |
|---|---|
| PubChem CID | 161397962 |
| Molecular Formula | C148H147F6N21O17S2 |
| Molecular Weight | 2670.06 g/mol |
| Exact Mass | 2668.06 |
| IUPAC Name | N-[3-(2-aminoethoxy)phenyl]-4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]pyrimidin-2-amine;tert-butyl 4-[2-[3-[[4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]pyrimidin-2-yl]amino]phenoxy]ethyl]piperazine-1-carboxylate;4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-N-[3-(2-methylsulfonylethyl)phenyl]pyrimidin-2-amine;4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-N-[4-(methylsulfonylmethyl)phenyl]pyrimidin-2-amine;4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]-N-[3-(oxan-4-yloxy)phenyl]pyrimidin-2-amine;1-[3-[[4-[(4-fluoro-2-methyl-1H-inden-5-yl)oxy]pyrimidin-2-yl]amino]phenyl]pentan-1-one |
| SMILES | CC1=Cc2c(ccc(Oc3ccnc(Nc4ccc(CS(C)(=O)=O)cc4)n3)c2F)C1.CC1=Cc2c(ccc(Oc3ccnc(Nc4cccc(CCS(C)(=O)=O)c4)n3)c2F)C1.CC1=Cc2c(ccc(Oc3ccnc(Nc4cccc(OC5CCOCC5)c4)n3)c2F)C1.CC1=Cc2c(ccc(Oc3ccnc(Nc4cccc(OCCN)c4)n3)c2F)C1.CC1=Cc2c(ccc(Oc3ccnc(Nc4cccc(OCCN5CCN(C(=O)OC(C)(C)C)CC5)c4)n3)c2F)C1.CCCCC(=O)c1cccc(Nc2nccc(Oc3ccc4c(c3F)C=C(C)C4)n2)c1 |
| InChI | InChI=1S/C31H36FN5O4.C25H24FN3O3.C25H24FN3O2.C23H22FN3O3S.C22H21FN4O2.C22H20FN3O3S/c1-21-18-22-8-9-26(28(32)25(22)19-21)40-27-10-11-33-29(35-27)34-23-6-5-7-24(20-23)39-17-16-36-12-14-37(15-13-36)30(38)41-31(2,3)4;1-16-13-17-5-6-22(24(26)21(17)14-16)32-23-7-10-27-25(29-23)28-18-3-2-4-20(15-18)31-19-8-11-30-12-9-19;1-3-4-8-21(30)18-6-5-7-19(15-18)28-25-27-12-11-23(29-25)31-22-10-9-17-13-16(2)14-20(17)24(22)26;1-15-12-17-6-7-20(22(24)19(17)13-15)30-21-8-10-25-23(27-21)26-18-5-3-4-16(14-18)9-11-31(2,28)29;1-14-11-15-5-6-19(21(23)18(15)12-14)29-20-7-9-25-22(27-20)26-16-3-2-4-17(13-16)28-10-8-24;1-14-11-16-5-8-19(21(23)18(16)12-14)29-20-9-10-24-22(26-20)25-17-6-3-15(4-7-17)13-30(2,27)28/h5-11,19-20H,12-18H2,1-4H3,(H,33,34,35);2-7,10,14-15,19H,8-9,11-13H2,1H3,(H,27,28,29);5-7,9-12,14-15H,3-4,8,13H2,1-2H3,(H,27,28,29);3-8,10,13-14H,9,11-12H2,1-2H3,(H,25,26,27);2-7,9,12-13H,8,10-11,24H2,1H3,(H,25,26,27);3-10,12H,11,13H2,1-2H3,(H,24,25,26) |
| InChIKey | VTVYKAFLOPIATR-UHFFFAOYSA-N |
| XLogP | 32.00 |
| TPSA | 463.31 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 42 |
| Heavy Atoms | 194 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2670.06 |
| LogP ≤ 5 | 32.00 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 37 |